台股 » 順藥 » 個股財報 » 每股盈餘成長率(季增率)
- 股價
353.0
- 漲跌
▼19.5
- 漲幅
-5.23%
- 成交量
1,012張
- 產業
上櫃 生技醫療類股
▼0.42%
-
本地時間:14:30
順藥 (6535) 財務報表－每股盈餘成長率(季增率)
EPS成長率
EPS季增率 = (單季EPS÷上季EPS)-1。
EPS年增率 = (單季EPS÷去年同季EPS)-1。
順藥 (6535) 歷年EPS季增率
| 年度/季別 | EPS季增率 | 近4季EPS季增率 | 年度/季別 | EPS季增率 | 近4季EPS季增率 |
|---|
| 2024Q3 | -441.46% | 37.93% | 2021Q3 | -518.92% | -263.16% |
| 2024Q2 | -157.75% | -43.32% | 2021Q2 | -260.87% | 5.56% |
| 2024Q1 | 1.43% | 108.84% | 2021Q1 | -170.77% | -52.81% |
| 2023Q4 | -5.41% | 177.36% | 2020Q4 | 62.5% | -5.65% |
| 2023Q3 | -19.57% | -28.38% | 2020Q3 | -40.3% | -8.71% |
| 2023Q2 | -203.37% | -27.45% | 2020Q2 | -29.47% | 34.2% |
| 2023Q1 | 270.83% | -66.56% | 2020Q1 | 17.28% | 12.68% |
| 2022Q4 | -125.26% | -44.24% | 2019Q4 | 20.9% | 86.36% |
| 2022Q3 | -20.83% | 285.21% | 2019Q3 | -658.33% | 92.98% |
| 2022Q2 | 5.26% | 47.92% | 2019Q2 | -117.39% | -44.12% |
| 2022Q1 | -47.71% | -250% | 2019Q1 | -592.86% | 100% |
| 2021Q4 | -170.32% | -70.51% | | | |
順藥辦理現金增資 承銷價225元 抽中獲利上看16.2萬元Anue鉅亨－25天前
〈熱門股〉川普交易再起 順藥股價點火周漲逾2成Anue鉅亨－28天前
〈焦點股〉川普交易再現帶旺生技族群 順藥亮燈漲停Anue鉅亨－30天前